The Stock Watcher
Sign InSubscribe
Stocks

4 Best Penny Stocks to Watch in February 2023

 
Share this article

4 penny stocks to watch in February 2023: PYPD, ETON, APRE, FRTX.

Image of four different penny stocks to watch in February 2023.

Are you looking for the best penny stocks to buy in February 2023? If so, you’ve come to the right place. In this article, we’ll take a look at four penny stocks that have been turning heads on Wall Street. These stocks are PolyPid Ltd. (NASDAQ:PYPD), Eaton Pharmaceuticals (NASDAQ:ETON), Aprea Therapeutics Inc. (NASDAQ:APRE), and Fresh Tracks Therapeutics (NASDAQ:FRTX).

PolyPid Ltd. (NASDAQ:PYPD) is a clinical-stage biotechnology company that is focused on developing novel treatments for patients with serious infections. The company’s two core platforms, UltraCAR-T and UltraCAR-B, have the potential to revolutionize the treatment of antibiotic-resistant infections. Wall Street analysts are expecting big things from PolyPid in 2023, especially after the company announced that it had raised $50 million in a private placement.

Eaton Pharmaceuticals (NASDAQ:ETON) is a specialty pharmaceutical company that develops and manufactures generic and branded drugs. The company’s pipeline of products includes products for the treatment of asthma, diabetes, and cardiovascular diseases. The company is also working on a number of promising new products, including a generic version of Lantus, which is a long-acting insulin product.

Aprea Therapeutics Inc. (NASDAQ:APRE) is a biopharmaceutical company that is focused on developing drugs to treat cancer and other diseases. The company’s lead product, APG-2575, is a novel small molecule that is being tested in clinical trials for the treatment of ovarian cancer. The company has also entered into a strategic collaboration with the Cystic Fibrosis Foundation to develop new treatments for cystic fibrosis.

Finally, Fresh Tracks Therapeutics (NASDAQ:FRTX) is a biopharmaceutical company that is focused on developing treatments for rare diseases. The company’s lead product, FRTX-101, is a novel small molecule that is being tested in clinical trials for the treatment of Huntington’s disease. The company is also working on a number of other promising new products, including a treatment for mitochondrial diseases.

So if you’re looking for the best penny stocks to buy in February 2023, these four stocks are worth a closer look. Keep an eye on PolyPid Ltd. (NASDAQ:PYPD), Eaton Pharmaceuticals (NASDAQ:ETON), Aprea Therapeutics Inc. (NASDAQ:APRE), and Fresh Tracks Therapeutics (NASDAQ:FRTX) and see if they can continue to live up to the expectations of Wall Street analysts.

Labels:
penny stocksfebruary 2023polypid ltd. (pypd)eaton pharmaceuticals (eton)aprea therapeutics inc. (apre)fresh tracks therapeutics (frtx)NASDAQ:PYPDNASDAQ:ETONNASDAQ:APRENASDAQ:FRTX

May Interest You

Share this article
logo
3640 Concord Pike Wilmington, DE 19803
About
About TheStockWatcher
© 2024 - TheStockWatcher. All Rights Reserved